Regular ArticleSerum-Free Culture Conditions for Analysis of Secretory Proteinases during Myogenic Differentiation of Mouse C2C12 Myoblasts☆
References (36)
Cell
(1993)Dev. Biol.
(1992)- et al.
J. Biol. Chem.
(1998) - et al.
J. Biol. Chem.
(1998) - et al.
FEBS Lett.
(1993) - et al.
Exp. Cell Res.
(1997) - et al.
Dev. Biol.
(1986) - et al.
Dev. Biol.
(1987) - et al.
Exp. Cell Res.
(1997) - et al.
Differentiation
(1977)
Exp. Cell Res.
Dev. Biol.
Exp. Cell Res.
Int. J. Dev. Neurosci.
Life Sci.
Int. J. Dev. Neurosci.
Dev. Biol.
Cited by (32)
The roles of supernatant of macrophage treated by excretory-secretory products from muscle larvae of Trichinella spiralis on the differentiation of C2C12 myoblasts
2016, Veterinary ParasitologyCitation Excerpt :Several experimental studies have demonstrated that low concentration horse serum is capable of effectively inducing C2C12 myoblasts to differentiate into mature myocytes. For example, exposure to 2% (v/v) HS was shown to bear a higher effect (Goto et al., 1999; Langen et al., 2003). Based on these studies, we assessed the effects of CM on the differentiation of myoblasts in a culture medium contained 2% (v/v) HS, with the control group.
Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone
2004, Toxicology and Applied PharmacologyDevelopment of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells
2003, Biochemical PharmacologyCitation Excerpt :Recent studies have provided evidences that C2C12 skeletal muscle cells can be differentiated in serum-free medium [28–30]. It has been reported that addition of insulin is required to differentiate C2C12 myoblasts in serum-free medium [28,29]. In our culture media, C2C12 cells were differentiated normally in MF in the presence as well as in the absence of insulin.
- ☆
This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, and Science of Japan.
- 2
To whom correspondence should be addressed. Fax: (+81)-45-820-1901. E-mail: [email protected].